The entire orthopedic industry is watching this unprecedented FDA relook?
Does the FDA have the authority to take back a 510(k)? If so, on what basis? What impact will this have on your 510(k) cleared products? Read recent publications below...
FDA Agenda and Meeting Materials FDA.gov
FDA Wrestles With Undoing Decision WSJ (Mar 22)
UPDATE: FDA:Not Enough Data From ReGen To Show Knee Device Safe WSJ (Mar 19)
ReGen: Resurrection or Final Nail OrthopedicsThisWeek (Mar 4)
FDA: Menaflex Clearance Shows "Definite Threats" to the 510(k) Process HealthPointCapital (Sept 24)
FDA Repor...
